John Hohneker

Insider Reports History

Location
Cambridge, MA
Signature
By: /s/ James Kastenmayer, Attorney-in-Fact for John Hohneker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Hohneker:

Form 4 holding Director

HUMANIGEN, INC

Security class
Stock Option (Right to Buy)
Shares / value
63,195
Estimated value
$286,273
Report date
27 Jul 2022
Price
$4.53
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CURIS INC

Security class
Non Qualified Stock Option
Shares / value
14,400
Estimated value
$45,072
Report date
20 May 2025
Price
$3.13
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Aravive, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
97,063
Estimated value
Report date
23 Sep 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Evelo Biosciences, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
20,000
Estimated value
Report date
08 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Carisma Therapeutics Inc.

Security class
Stock Option (Right to Buy)
Shares / value
19,350
Estimated value
Report date
26 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ArriVent BioPharma, Inc.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
15,502
Estimated value
Report date
18 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John Hohneker

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .